SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-24-033368
Filing Date
2024-08-21
Accepted
2024-08-21 07:00:14
Documents
3
Period of Report
2024-08-21

Document Format Files

Seq Description Document Type Size
1 form6-k.htm 6-K 23461
2 ex99-1.htm EX-99.1 10735
3 ex99-1_001.jpg GRAPHIC 27106
  Complete submission text file 0001493152-24-033368.txt   72623
Mailing Address 55 PARK LANE LONDON X0 W1K 1NA
Business Address 55 PARK LANE LONDON X0 W1K 1NA 44 (0) 207 495 2379
OKYO Pharma Ltd (Filer) CIK: 0001849296 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 001-41386 | Film No.: 241227185
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)